US · TDAC
Translational Development Acquisition Corp.
Programmatic access: InvestorsCraft Valuation API · catalog
Price · as of 2025
$10.86
Market cap 267.11M
Valuation
| Metric | Value | Upside |
|---|---|---|
| IC Value | — | — |
| P/E | 28.58 | |
| P/B | 1.04 | |
| P/S | — | |
| EV/EBITDA | -192.67 | |
| PEG | — | |
| P/TBV | 1.04 |
Valuation history
Annual price overlaid with each model's fair value. Y-axis is log scale.
| Year | Price | AI | IC | Graham-Dodd | Graham Formula |
|---|---|---|---|---|---|
| 2011 | |||||
| 2012 | |||||
| 2013 | |||||
| 2014 | |||||
| 2015 | |||||
| 2016 | |||||
| 2017 | |||||
| 2018 | |||||
| 2019 | |||||
| 2020 | |||||
| 2021 | |||||
| 2022 | |||||
| 2023 | |||||
| 2024 | $10.06 | ||||
| 2025 | $10.54 |
Historic valuation ratios
Pick a category, then toggle metrics to compare.
Line items
Line items
Line items
About Translational Development Acquisition Corp.
Translational Development Acquisition Corp., founded in 2022 and headquartered in New York, New York, currently conducts no significant business operations. Its primary goal is to complete a business combination, such as a merger, amalgamation, share exchange, asset acquisition, share purchase, or reorganization, with one or more companies.
- CEO
- Michael Hoffman
- Employees
- 2
- Beta
- 0.01
Scroll horizontally for additional metrics. Ticker column stays fixed.
| Basic Info | IC Valuation | Core Valuation | Profitability | Leverage & Liquidity | Growth | Cash Flow | Dividends | Enterprise Value | Risk | ||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ticker | Company Name | Price | Market Cap | Value | Upside | P/E | P/B | P/S | EV/EBITDA | PEG | P/TBV | Gross Margin | Operating Margin | Net Margin | ROE | ROIC | ROA | Debt/Equity | Interest Coverage | Current Ratio | Quick Ratio | Net Debt/EBITDA | EPS Growth | Sales Growth | FCF Growth | FCF Yield | Op Cash Flow Ratio | Cash ROIC | Dividend Yield | Dividend Payout | Shareholder Yield | EV/EBIT | EV/FCF | EV/Sales | Altman Z-Score |
| TDAC | Translational Development… | $10.86 | 267.11M | — | — | 28.58 | 1.04 | — | -192.67 | — | 1.04 | 0.00% | 0.00% | 0.00% | 3.70% | 0.00% | 3.57% | 0.00 | — | 0.07 | 0.05 | -0.18 | -2383.95% | -100.00% | -28.55% | -0.33% | -1.12 | 0.00% | 0.00% | 0.00% | 0.00% | -192.67 | -299.13 | — | 16.50 |
| CEPO | Cantor Equity Partners I,… | $10.65 | 218.33M | — | — | -40.14 | 1.38 | — | -274.97 | -0.52 | 1.38 | 0.00% | 0.00% | 0.00% | -6.88% | -1.00% | -6.40% | 0.00 | — | 0.26 | 0.03 | -0.47 | 7778.79% | — | -139.17% | 0.02% | 0.07 | 0.05% | 0.00% | 0.00% | 0.00% | -274.97 | 5091.49 | — | 11.32 |
| FACT | FACT II Acquisition Corp | $10.66 | 259.27M | — | — | 38.62 | 1.11 | — | -86.84 | — | 1.11 | 0.00% | 0.00% | 0.00% | 12.91% | -2.09% | 3.05% | 0.00 | — | 27.11 | 23.18 | 0.24 | -111.95% | -100.00% | -98.35% | -0.47% | -38.42 | -0.85% | 0.00% | 0.00% | 70.58% | -86.84 | -213.93 | — | 12.59 |
| HCMA | HCM Acquisition Corp | $10.27 | 135.4M | — | — | 155.67 | 1.40 | — | -372.30 | — | 1.40 | 0.00% | 0.00% | 0.00% | — | — | — | 0.00 | — | 1.64 | 1.53 | 1.11 | — | — | — | -0.10% | -0.53 | — | 0.00% | 0.00% | 0.00% | -372.30 | -958.08 | — | 14.64 |
| MACI | Melar Acquisition Corp. I | $10.92 | 236.11M | — | — | 31.02 | 1.05 | — | -2.79 | 84.20 | 1.05 | 0.00% | 0.00% | 0.00% | 3.43% | -1.91% | 3.25% | 0.02 | -2.73 | 0.91 | 40.80 | -2.50 | 36.84% | — | 42.01% | -0.45% | -0.18 | -1.00% | 0.00% | 0.00% | 0.00% | -2.79 | -5.32 | — | 9.38 |
| SZZL | Sizzle Acquisition Corp. … | $10.38 | 244.97M | — | — | 27.97 | 0.80 | — | 105.82 | — | 0.80 | 0.00% | 0.00% | 0.00% | 5.70% | 9.90% | 5.43% | 0.00 | — | 6.71 | 1711.90 | 1.50 | -1931.68% | — | — | -0.33% | -4.32 | 11.07% | 0.00% | 0.00% | 0.51% | 105.82 | 94.66 | — | 9.73 |
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Upside computed as (— ÷ $10.86) − 1 = — (IC, example).